Infections, including intracranial abscesses, are a well-known and potentially serious complication of intravenous drug abuse. There have been increasing reports of intravenous misuse of transdermal Fentanyl, with severe sequelae. Intracranial abscesses in intravenous drug users tend to involve uncommon pathogens, and may present with atypical symptoms, which can lead to delayed diagnosis and inadequate treatment. We present the case of a 28-year-old female, with a history of intravenous misuse of transdermal Fentanyl, who was found to have intracranial abscesses with Fusobacterium nucleatum and Nocardia species, causing significant vasogenic oedema and mass effect.
Introduction
Infections are a well-known and potentially serious complication of intravenous drug abuse [1] . These infections include intracranial abscesses, which may occur due to the use of non-sterile injections and contamination of the injected substance, as well as life-style practices and impaired host immunity [1] . Most reported cases of drug abuse related intracranial abscesses are due to injection of illegal drugs, such as heroin and amphetamines. There have been increasing reports of intravenous abuse of transdermal Fentanyl, with the main complication being related to respiratory depression, with no published reports of intracranial abscesses related to this [2] 
Case Description
A 28-year-old female, with a history of intravenous drug use, presented to the emergency department with a two day history of worsening headaches and photophobia. She denied any fevers, nausea or rash. She denied a history of migraines, but did report recurrent intravenous use of transdermal Fentanyl patches. On physical examination, she was afebrile and haemodynamically sta- 
Discussion
Infectious complications of substance abuse are a frequent cause of hospital admissions, with atypical poly-microbial pathogens, and uncommon types and sites of infection [1] . It is important to be aware of this while choosing appropriate antimicrobial therapies, as delay in effective treatment may worsen patient outcomes [4] . Central nervous system infections and related complications remain a major source of mortality and morbidity, and necessitate a multidisciplinary treatment approach [5] [6].
Frontal lobe abscesses frequently present with subtle clinical symptoms, leading to this lobe being referred to as the "silent area" of the brain [5] . Neuro-imaging, such as a contrast CT scan, is essential for the diagnosis of intracranial abscesses, and is useful to aid early characterisation, localisation and staging of these abscesses [5] . Surgical intervention is required not only to reduce mass effect, but also to facilitate confirmation of the diagnosis, characterisation of the involved pathogens, and to guide appropriate antibiotic therapy [5] . Infectious diseases input and microbiological studies are essential in guiding antibiotic choice and duration [5] . This patient, with two large frontal abscesses and associated mass effect, required prompt diagnosis, urgent neurosurgical decompression and appropriate antibiotic cover. Experimental studies have demonstrated the effect of Dexamethasone in reducing cerebral oedema associated with intracranial abscesses, although it may impair the host's immune response as well as reduce antibiotic efficacy [7] .
Nocardial intracranial abscesses are rare, however studies have shown a mortality rate of greater than 47% in patients with these abscesses [8] [9] . Fusobacterium species are found in around 6% of intracranial abscess, and most patients tend to survive [4] [10] . In this case, given no detection of an extracranial focus of infection, it is possible that parenteral inoculation had occurred.
Fentanyl misuse has become increasingly common in recent years and continues to rise [3] . This is an interesting case highlighting a potentially severe complication of intravenous use of transdermal Fentanyl. Clinicians should be aware of this potential diagnosis, and should attempt to rule out intracranial abscess in intravenous drug users who present with significant neurological symptoms, even if these are atypical, and arrange urgent investigation and intervention to prevent impending sequelae.
Conclusion
The potential for the abuse of Fentanyl has been well established. This report could serve to raise awareness of the possibility of the serious complication of developing an intracranial abscess secondary to injecting transdermal Fentanyl, as well as the rare pathogens involved. Severe cases require a multidisciplinary approach with urgent intervention as well as early microbiological studies and tailoring of antibiotic treatment.
